Product Information
Registration Status: ActivePRIORIX VACCINE is approved to be sold in Singapore with effective from 1999-03-22. It is marketed by GLAXOSMITHKLINE PTE LTD, with the registration number of SIN10822P.
This product contains Measles Virus (Schwarz Strain) (Live Attenuated) min 1000 TCID50,Mumps Virus (Rit 4385 Strain) (Live Attenuated) min 5000 TCID50, and Rubella Virus (Ra27/3 Strain) (Live Attenuated) min 1000 TCID50 in the form of INJECTION, POWDER, FOR SOLUTION. It is approved for SUBCUTANEOUS, INTRAMUSCULAR use.
This product is manufactured by GLAXOSMITHKLINE BIOLOGICALS SA in UNITED STATES,Fidia Farmaceutici S.P.A in BELGIUM,GlaxoSmithKline Biologicals - Diluent in ampoules in ITALY,Delpharm Tours - Diluent in ampoules in FRANCE, andCorixa Corporation d/b/a GlaxoSmithKline Vaccines in GERMANY.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.